Your Messages Inbox
Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
See Latest ArticlesSafety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding
Inflammatory Bowel Disease, 11/04/09
Gisbert JP et al. – Certolizumab differs from infliximab and adalimumab in that it is a Fab fragment of an antitumor necrosis factor alpha monoclonal antibody, and therefore it may not be necessary to stop certolizumab in the third trimester. The use of infliximab is probably compatible with breast–feeding.
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Pregnancy and Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/16/09
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09
Sponsor
Article Search
Sponsor
Sponsor